Position in KRYS
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$1,115
+$341 QoQ
Shares Held
3
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#403
of 419 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cedar Mountain Advisors, LLC holds $222,688 across 33 Biotechnology names. KRYS ranks #21 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
115 | $27,711 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54 | $26,823 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
223 | $17,681 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
66 | $16,154 | |
| 5 | EYPT |
EyePoint, Inc.
|
1,000 | $14,300 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
113 | $13,851 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22 | $13,717 | |
| 8 | INSM |
INSMED Inc
|
118 | $12,581 |
All Filings in KRYS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,115 | 3 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $774 | 3 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||